(PubMed) Levine M, Rumsey SC, Daruwala R, Park JB, Wang Y
Clinical Evidence HIV patients: 26-week trials show 20% reduction in abdominal fat Metabolic syndrome patients: Improvements in triglycerides, liver fat, and insulin sensitivity Ideal Candidates for Tesamorelin People with visceral obesity Patients with metabolic syndrome or insulin resistance Individuals able to commit to daily injections and lab monitoring Ipamorelin: Gentle Growth Hormone Booster Ipamorelin is a selective ghrelin receptor agonist that stimulates GH without significantly affecting cortisol, prolactin, or ACTH
What the Science Says: Olive Oil, Polyphenols, and Metabolic Health This is where the research becomes genuinely interesting
A pharmacy may be allowed to prepare a product under limited circumstances without the product becoming an FDA-approved treatment
The American journal of clinical nutrition